• New

Retatrutide 5mg

$380.00
No tax

What is Retatrutide?

Retatrutide is an experimental medication being studied for its potential in treating obesity and type 2 diabetes. As part of a new class of drugs called GGG tri-agonists, Retatrutide works by targeting three hormone receptors in the body:

  • Appetite control

  • Feeling of fullness

  • Metabolism regulation

By acting on these pathways, scientists hope Retatrutide will help with significant weight loss.

How is Retatrutide Used in Clinical Studies?

1. Administration

  • Injection: Retatrutide is administered as a subcutaneous (under the skin) injection.

  • Frequency: Most studies use a once-weekly injection.

  • Injection Sites: Common sites include the abdomen, thigh, or upper arm. Injection spots are rotated weekly.

2. Dosage in Trials

  • Start Low: Dosing typically begins low (e.g., 0.5 mg, 1 mg, or 2 mg per week).

  • Gradual Increase: If well-tolerated, the dose is slowly increased (titrated) over time.

  • Maximum Studied Doses: Some studies go up to 12 mg per week or more.

  • Supervised by Doctors: All dosing is strictly managed by clinical trial doctors.

3. Medical Supervision

  • Close Monitoring: Participants are supervised by doctors and research staff.

  • Regular Safety Checks: Health and side effects are monitored throughout the study.

  • Expert Guidance: Only professionals can determine safe and effective use in a research setting.

What Do Researchers Hope Retatrutide Can Do?

Early and ongoing trials suggest Retatrutide could:

  • Promote significant weight loss at higher doses.

  • Improve metabolic health (e.g., blood sugar, cholesterol).

Possible Side Effects Seen in Studies

The most common side effects reported are:

  • Nausea

  • Diarrhea

  • Vomiting

  • Constipation

These are usually mild to moderate and may improve as the body adjusts. All side effects are monitored and managed by the clinical trial team.